microRNA-219 Reduces Viral Load and Pathologic Changes in Theiler's Virus-Induced Demyelinating Disease
Open Access
- 1 March 2018
- journal article
- research article
- Published by Elsevier in Molecular Therapy
- Vol. 26 (3) , 730-743
Abstract
No abstract availableKeywords
Funding Information
- NIH (R21NS087474)
- National Multiple Sclerosis Society (RG 4172)
- NIH (R01NS072427)
- National Multiple Sclerosis Society (NMSS-RG-1507)
- NIH (NS065945)
- Modestus Bauer Foundation
This publication has 64 references indexed in Scilit:
- Intranasal Delivery of HMGB1 siRNA Confers Target Gene Knockdown and Robust Neuroprotection in the Postischemic BrainMolecular Therapy, 2012
- Global quantification of mammalian gene expression controlNature, 2011
- Dicer1 and miR-219 Are Required for Normal Oligodendrocyte Differentiation and MyelinationNeuron, 2010
- Dicer ablation in oligodendrocytes provokes neuronal impairment in miceAnnals of Neurology, 2009
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression dataBioinformatics, 2009
- Neuropathogenesis of Theiler’s Murine Encephalomyelitis Virus Infection, An Animal Model for Multiple SclerosisJournal of Neuroimmune Pharmacology, 2009
- MicroRNAs: Target Recognition and Regulatory FunctionsCell, 2009
- Multiple sclerosisThe Lancet, 2008
- Analysis of nociception, sex and peripheral nerve innervation in the TMEV animal model of multiple sclerosisPain, 2008
- Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue.Journal of Cell Biology, 1980